Access to Medicines as a Human Right: Implications for Pharmaceutical Industry Responsibility
According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the pr...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Toronto
University of Toronto Press
[2018]
|
| Schlagworte: | |
| Online-Zugang: | FHA01 FKE01 FLA01 UPA01 FAW01 FAB01 FCO01 Volltext |
| Zusammenfassung: | According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health?This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue |
| Beschreibung: | Description based on online resource; title from PDF title page (publisher's Web site, viewed 23. Nov 2018) |
| Beschreibung: | 1 online resource 3 tables |
| ISBN: | 9781442698277 |
| DOI: | 10.3138/9781442698277 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV045879388 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 190515s2018 |||| o||u| ||||||eng d | ||
| 020 | |a 9781442698277 |9 978-1-4426-9827-7 | ||
| 024 | 7 | |a 10.3138/9781442698277 |2 doi | |
| 035 | |a (ZDB-23-DGG)9781442698277 | ||
| 035 | |a (OCoLC)1101922427 | ||
| 035 | |a (DE-599)BVBBV045879388 | ||
| 040 | |a DE-604 |b ger |e rda | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-Aug4 |a DE-859 |a DE-860 |a DE-739 |a DE-1046 |a DE-1043 |a DE-858 | ||
| 082 | 0 | |a 174.2951 | |
| 100 | 1 | |a Forman, Lisa |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Access to Medicines as a Human Right |b Implications for Pharmaceutical Industry Responsibility |c Lisa Forman, Jillian Clare Kohler |
| 264 | 1 | |a Toronto |b University of Toronto Press |c [2018] | |
| 264 | 4 | |c © 2012 | |
| 300 | |a 1 online resource |b 3 tables | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 500 | |a Description based on online resource; title from PDF title page (publisher's Web site, viewed 23. Nov 2018) | ||
| 520 | |a According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health?This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue | ||
| 546 | |a In English | ||
| 650 | 4 | |a Human rights |x Health aspects | |
| 650 | 4 | |a Pharmaceutical ethics | |
| 650 | 4 | |a Pharmaceutical industry |x Moral and ethical aspects | |
| 650 | 4 | |a Social responsibility of business | |
| 650 | 0 | 7 | |a Ethik |0 (DE-588)4015602-3 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Soziale Verantwortung |0 (DE-588)4055737-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Verantwortungsethik |0 (DE-588)4236475-9 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |2 gnd |9 rswk-swf |
| 655 | 7 | |8 1\p |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 655 | 7 | |8 2\p |0 (DE-588)4522595-3 |a Fallstudiensammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 0 | 1 | |a Soziale Verantwortung |0 (DE-588)4055737-6 |D s |
| 689 | 0 | 2 | |a Ethik |0 (DE-588)4015602-3 |D s |
| 689 | 0 | |8 3\p |5 DE-604 | |
| 689 | 1 | 0 | |a Pharmazeutische Industrie |0 (DE-588)4045696-1 |D s |
| 689 | 1 | 1 | |a Verantwortungsethik |0 (DE-588)4236475-9 |D s |
| 689 | 1 | |8 4\p |5 DE-604 | |
| 700 | 1 | |a Kohler, Jillian Clare |4 aut | |
| 856 | 4 | 0 | |u https://doi.org/10.3138/9781442698277 |x Verlag |z URL des Erstveröffentlichers |3 Volltext |
| 912 | |a ZDB-23-DGG | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-031262564 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 2\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 3\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 883 | 1 | |8 4\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
| 966 | e | |u https://doi.org/10.3138/9781442698277 |l FHA01 |p ZDB-23-DGG |q FHA_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.3138/9781442698277 |l FKE01 |p ZDB-23-DGG |q FKE_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.3138/9781442698277 |l FLA01 |p ZDB-23-DGG |q FLA_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.3138/9781442698277 |l UPA01 |p ZDB-23-DGG |q UPA_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.3138/9781442698277 |l FAW01 |p ZDB-23-DGG |q FAW_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.3138/9781442698277 |l FAB01 |p ZDB-23-DGG |q FAB_PDA_DGG |x Verlag |3 Volltext | |
| 966 | e | |u https://doi.org/10.3138/9781442698277 |l FCO01 |p ZDB-23-DGG |q FCO_PDA_DGG |x Verlag |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804180027080704001 |
|---|---|
| any_adam_object | |
| author | Forman, Lisa Kohler, Jillian Clare |
| author_facet | Forman, Lisa Kohler, Jillian Clare |
| author_role | aut aut |
| author_sort | Forman, Lisa |
| author_variant | l f lf j c k jc jck |
| building | Verbundindex |
| bvnumber | BV045879388 |
| collection | ZDB-23-DGG |
| ctrlnum | (ZDB-23-DGG)9781442698277 (OCoLC)1101922427 (DE-599)BVBBV045879388 |
| dewey-full | 174.2951 |
| dewey-hundreds | 100 - Philosophy & psychology |
| dewey-ones | 174 - Occupational ethics |
| dewey-raw | 174.2951 |
| dewey-search | 174.2951 |
| dewey-sort | 3174.2951 |
| dewey-tens | 170 - Ethics (Moral philosophy) |
| discipline | Philosophie |
| doi_str_mv | 10.3138/9781442698277 |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04519nmm a2200709zc 4500</leader><controlfield tag="001">BV045879388</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">190515s2018 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781442698277</subfield><subfield code="9">978-1-4426-9827-7</subfield></datafield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.3138/9781442698277</subfield><subfield code="2">doi</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ZDB-23-DGG)9781442698277</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)1101922427</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV045879388</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rda</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-Aug4</subfield><subfield code="a">DE-859</subfield><subfield code="a">DE-860</subfield><subfield code="a">DE-739</subfield><subfield code="a">DE-1046</subfield><subfield code="a">DE-1043</subfield><subfield code="a">DE-858</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">174.2951</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Forman, Lisa</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Access to Medicines as a Human Right</subfield><subfield code="b">Implications for Pharmaceutical Industry Responsibility</subfield><subfield code="c">Lisa Forman, Jillian Clare Kohler</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Toronto</subfield><subfield code="b">University of Toronto Press</subfield><subfield code="c">[2018]</subfield></datafield><datafield tag="264" ind1=" " ind2="4"><subfield code="c">© 2012</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource</subfield><subfield code="b">3 tables</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Description based on online resource; title from PDF title page (publisher's Web site, viewed 23. Nov 2018)</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings&apos; right to health?This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies&apos; social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">In English</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Human rights</subfield><subfield code="x">Health aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical ethics</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Pharmaceutical industry</subfield><subfield code="x">Moral and ethical aspects</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Social responsibility of business</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Soziale Verantwortung</subfield><subfield code="0">(DE-588)4055737-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Verantwortungsethik</subfield><subfield code="0">(DE-588)4236475-9</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">1\p</subfield><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="8">2\p</subfield><subfield code="0">(DE-588)4522595-3</subfield><subfield code="a">Fallstudiensammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Soziale Verantwortung</subfield><subfield code="0">(DE-588)4055737-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Ethik</subfield><subfield code="0">(DE-588)4015602-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="8">3\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Pharmazeutische Industrie</subfield><subfield code="0">(DE-588)4045696-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Verantwortungsethik</subfield><subfield code="0">(DE-588)4236475-9</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kohler, Jillian Clare</subfield><subfield code="4">aut</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.3138/9781442698277</subfield><subfield code="x">Verlag</subfield><subfield code="z">URL des Erstveröffentlichers</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-23-DGG</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-031262564</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">2\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">3\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">4\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.3138/9781442698277</subfield><subfield code="l">FHA01</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FHA_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.3138/9781442698277</subfield><subfield code="l">FKE01</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FKE_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.3138/9781442698277</subfield><subfield code="l">FLA01</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FLA_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.3138/9781442698277</subfield><subfield code="l">UPA01</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">UPA_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.3138/9781442698277</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FAW_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.3138/9781442698277</subfield><subfield code="l">FAB01</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FAB_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">https://doi.org/10.3138/9781442698277</subfield><subfield code="l">FCO01</subfield><subfield code="p">ZDB-23-DGG</subfield><subfield code="q">FCO_PDA_DGG</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| genre | 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content 2\p (DE-588)4522595-3 Fallstudiensammlung gnd-content |
| genre_facet | Aufsatzsammlung Fallstudiensammlung |
| id | DE-604.BV045879388 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T08:29:13Z |
| institution | BVB |
| isbn | 9781442698277 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-031262564 |
| oclc_num | 1101922427 |
| open_access_boolean | |
| owner | DE-Aug4 DE-859 DE-860 DE-739 DE-1046 DE-1043 DE-858 |
| owner_facet | DE-Aug4 DE-859 DE-860 DE-739 DE-1046 DE-1043 DE-858 |
| physical | 1 online resource 3 tables |
| psigel | ZDB-23-DGG ZDB-23-DGG FHA_PDA_DGG ZDB-23-DGG FKE_PDA_DGG ZDB-23-DGG FLA_PDA_DGG ZDB-23-DGG UPA_PDA_DGG ZDB-23-DGG FAW_PDA_DGG ZDB-23-DGG FAB_PDA_DGG ZDB-23-DGG FCO_PDA_DGG |
| publishDate | 2018 |
| publishDateSearch | 2018 |
| publishDateSort | 2018 |
| publisher | University of Toronto Press |
| record_format | marc |
| spelling | Forman, Lisa Verfasser aut Access to Medicines as a Human Right Implications for Pharmaceutical Industry Responsibility Lisa Forman, Jillian Clare Kohler Toronto University of Toronto Press [2018] © 2012 1 online resource 3 tables txt rdacontent c rdamedia cr rdacarrier Description based on online resource; title from PDF title page (publisher's Web site, viewed 23. Nov 2018) According to the World Health Organization, one-third of the global population lacks access to essential medicines. Should pharmaceutical companies be ethically or legally responsible for providing affordable medicines for these people, even though they live outside of profitable markets? Can the private sector be held accountable for protecting human beings' right to health?This thought-provoking interdisciplinary collection grapples with corporate responsibility for the provision of medicines in low- and middle-income countries. The book begins with an examination of human rights, norms, and ethics in relation to the private sector, moving to consider the tensions between pharmaceutical companies' social and business duties. Broad examinations of global conditions are complemented by case studies illustrating different approaches for addressing corporate conduct. Access to Medicines as a Human Right identifies innovative solutions applicable in both global and domestic forums, making it a valuable resource for the vast field of scholars, legal practitioners, and policymakers who must confront this challenging issue In English Human rights Health aspects Pharmaceutical ethics Pharmaceutical industry Moral and ethical aspects Social responsibility of business Ethik (DE-588)4015602-3 gnd rswk-swf Soziale Verantwortung (DE-588)4055737-6 gnd rswk-swf Verantwortungsethik (DE-588)4236475-9 gnd rswk-swf Pharmazeutische Industrie (DE-588)4045696-1 gnd rswk-swf 1\p (DE-588)4143413-4 Aufsatzsammlung gnd-content 2\p (DE-588)4522595-3 Fallstudiensammlung gnd-content Pharmazeutische Industrie (DE-588)4045696-1 s Soziale Verantwortung (DE-588)4055737-6 s Ethik (DE-588)4015602-3 s 3\p DE-604 Verantwortungsethik (DE-588)4236475-9 s 4\p DE-604 Kohler, Jillian Clare aut https://doi.org/10.3138/9781442698277 Verlag URL des Erstveröffentlichers Volltext 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 2\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 3\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk 4\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | Forman, Lisa Kohler, Jillian Clare Access to Medicines as a Human Right Implications for Pharmaceutical Industry Responsibility Human rights Health aspects Pharmaceutical ethics Pharmaceutical industry Moral and ethical aspects Social responsibility of business Ethik (DE-588)4015602-3 gnd Soziale Verantwortung (DE-588)4055737-6 gnd Verantwortungsethik (DE-588)4236475-9 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| subject_GND | (DE-588)4015602-3 (DE-588)4055737-6 (DE-588)4236475-9 (DE-588)4045696-1 (DE-588)4143413-4 (DE-588)4522595-3 |
| title | Access to Medicines as a Human Right Implications for Pharmaceutical Industry Responsibility |
| title_auth | Access to Medicines as a Human Right Implications for Pharmaceutical Industry Responsibility |
| title_exact_search | Access to Medicines as a Human Right Implications for Pharmaceutical Industry Responsibility |
| title_full | Access to Medicines as a Human Right Implications for Pharmaceutical Industry Responsibility Lisa Forman, Jillian Clare Kohler |
| title_fullStr | Access to Medicines as a Human Right Implications for Pharmaceutical Industry Responsibility Lisa Forman, Jillian Clare Kohler |
| title_full_unstemmed | Access to Medicines as a Human Right Implications for Pharmaceutical Industry Responsibility Lisa Forman, Jillian Clare Kohler |
| title_short | Access to Medicines as a Human Right |
| title_sort | access to medicines as a human right implications for pharmaceutical industry responsibility |
| title_sub | Implications for Pharmaceutical Industry Responsibility |
| topic | Human rights Health aspects Pharmaceutical ethics Pharmaceutical industry Moral and ethical aspects Social responsibility of business Ethik (DE-588)4015602-3 gnd Soziale Verantwortung (DE-588)4055737-6 gnd Verantwortungsethik (DE-588)4236475-9 gnd Pharmazeutische Industrie (DE-588)4045696-1 gnd |
| topic_facet | Human rights Health aspects Pharmaceutical ethics Pharmaceutical industry Moral and ethical aspects Social responsibility of business Ethik Soziale Verantwortung Verantwortungsethik Pharmazeutische Industrie Aufsatzsammlung Fallstudiensammlung |
| url | https://doi.org/10.3138/9781442698277 |
| work_keys_str_mv | AT formanlisa accesstomedicinesasahumanrightimplicationsforpharmaceuticalindustryresponsibility AT kohlerjillianclare accesstomedicinesasahumanrightimplicationsforpharmaceuticalindustryresponsibility |